期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Metabolic Syndrome in People Living with HIV in Lome (Togo): Epidemiological Aspects and Associated Factors
1
作者 Abdou Razak Moukaila Edem Komi Mossi +8 位作者 Mouhaman-Inouwa Kpelafia Komi Dzidzonu Nemi Kossi Kodjo Agbeko Kodjo Djagadou Lidaw Déassoua Bawe Akessiwe Akouda Patassi Yawovi Mawufemo Tsevi ihou majesté wateba Awalou Mohaman Djibril 《Open Journal of Endocrine and Metabolic Diseases》 2020年第4期59-75,共17页
Introduction: People living with HIV (PLWHIV) are exposed to Metabolic Syndrome (MS), which increases their risk of having cardiovascular events and type 2 diabetes. No data on this subject is available in Togo. Objec... Introduction: People living with HIV (PLWHIV) are exposed to Metabolic Syndrome (MS), which increases their risk of having cardiovascular events and type 2 diabetes. No data on this subject is available in Togo. Objective: The objective of our study was to make an inventory of the metabolic syndrome among PLWHIV in Togo. Method: This was a prospective cross-sectional descriptive and analytical study on PLWHIV received at the day hospital of the Infectious Diseases Department of the Sylvanus Olympio University Hospital for a period of six months. Results: A total of 279 PLWHIV patients were enrolled, of which 237 (84.9%) were on Highly Active Antiretroviral Treatment (HAART) and 42 (15.1%) were naive. Metabolic syndrome has been demonstrated in 28.7% of the study population. Abdominal obesity was the most represented component of MS with a proportion of 57.7%. Risk factors associated with MS were female sex (OR = 3.01;CI: 1.52 - 5.93;p 2 (OR = 3.29;CI: 1.92 - 5.64;p 3 (OR = 1.85;CI: 1.06 - 3.20;p Conclusion: There is a need to screen MS for PLWHIV so that risk factors associated with it can be addressed early. 展开更多
关键词 HIV HAART Metabolic Syndrome DYSLIPIDEMIA Hypertension HYPERGLYCEMIA TOGO
下载PDF
Cryptococcal Meningitis of the HIV-Infected Person in Lomé: About 102 Cases over 10 Years
2
作者 ihou majesté wateba Abago Balaka +1 位作者 Alain Lidaw Bawe Awereou Kotosso 《World Journal of AIDS》 2017年第3期217-222,共6页
Objective: To describe the clinical, epidemiological and evolutionary aspects of cryptococcal meningitis. Methods: This was a retrospective descriptive study on all HIV-infected patients who had been hospitalized for ... Objective: To describe the clinical, epidemiological and evolutionary aspects of cryptococcal meningitis. Methods: This was a retrospective descriptive study on all HIV-infected patients who had been hospitalized for cryptococcal meningitis between 2006 and 2016 in the principal structures for the care of HIV infected person in Lomé. The diagnosis of meningitis was clinical and confirmed by the presence of cryptococci on Chinese ink or the detection of CSFsoluble antigens. All patients have made the CD4 rate assay and received an antifungal treatment based on fluconazole or Amphotericin B, followed later by antiretroviral triple therapy. Results: A total of 102 patients infected with cryptococcal meningitis (62 men for 40 women) were found. The sex ratio was 1.55. The median age was 34 years with extremes of 15 to 49 years. Clinically, headache was the symptomatic symptom in 100% of cases, prone to long runs and weight loss respectively in the proportions of 45% and 65%. The mean CD4 cell count was 65 ± 22 cells per mm3. The duration of hospital stay was short (less than 7 days) for the deceased. A total of 62 patients were able to receive treatment, 40 of them with fluconazole and 22 with Amphotericin B. The mortality was very high (65%), 25% were lost to follow-up, and 9.5% still in live 3 months after admission to the hospital. Conclusion: Cryptococcal meningitis has a very reserved prognosis. It is to be feared in cases of severe immunosuppression, hence the early detection of HIV for optimal management is important. 展开更多
关键词 CRYPTOCOCCAL MENINGITIS HIV Lomé
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部